Lunit Advances U.S. Entry Strategy with FDA Filing for Breast Cancer Risk AI, Strengthening Korea’s Healthtech Presence – KoreaTechDesk | Korean Startup and Technology News
Korean medical AI company Lunit is advancing its U.S. expansion by submitting its breast cancer risk prediction solution, Lunit INSIGHT…